These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8061516)

  • 21. Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication.
    Lenartowicz E; Nogales A; Kierzek E; Kierzek R; Martínez-Sobrido L; Turner DH
    Nucleic Acid Ther; 2016 Oct; 26(5):277-285. PubMed ID: 27463680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a specific intracellular localization of an antisense oligonucleotide in k562 cells.
    Vasconcelos MH; Maia LF; Sousa C; Beleza SS; Guimarães JE
    J Pharmacol Sci; 2005 Sep; 99(1):105-8. PubMed ID: 16141637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames.
    Liang XH; Shen W; Sun H; Migawa MT; Vickers TA; Crooke ST
    Nat Biotechnol; 2016 Aug; 34(8):875-80. PubMed ID: 27398791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of antisense oligonucleotides in vivo.
    Woolf TM; Melton DA; Jennings CG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7305-9. PubMed ID: 1380154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.
    Liang XH; Sun H; Shen W; Crooke ST
    Nucleic Acids Res; 2015 Mar; 43(5):2927-45. PubMed ID: 25712094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.
    Kilk K; Elmquist A; Saar K; Pooga M; Land T; Bartfai T; Soomets U; Langel U
    Neuropeptides; 2004 Oct; 38(5):316-24. PubMed ID: 15464198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the expression of muscle-specific genes mediated by troponin C antisense oligodeoxynucleotide.
    Thinakaran G; Bag J
    Exp Cell Res; 1991 Jan; 192(1):227-35. PubMed ID: 1984414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
    Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
    Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
    Braasch DA; Liu Y; Corey DR
    Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The probability of occurrence of oligomer motifs in the human genome and genomic microheterogeneity.
    MacLeod MC; Johnston DA; LaBate M; White RA
    J Theor Biol; 1996 Aug; 181(4):311-8. PubMed ID: 8949579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.
    Dyer PDR; Shepherd TR; Gollings AS; Shorter SA; Gorringe-Pattrick MAM; Tang CK; Cattoz BN; Baillie L; Griffiths PC; Richardson SCW
    J Control Release; 2015 Dec; 220(Pt A):316-328. PubMed ID: 26546271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of 2'-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides.
    Masaki Y; Iriyama Y; Nakajima H; Kuroda Y; Kanaki T; Furukawa S; Sekine M; Seio K
    Nucleic Acid Ther; 2018 Oct; 28(5):307-311. PubMed ID: 30020852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of VEGF mRNA by 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) antisense oligonucleotides and their influence on off-target gene expressions.
    Morita K; Yamate K; Kurakata S; Abe K; Watanabe K; Koizumi M; Imanishi T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):503-21. PubMed ID: 16838842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy.
    Watt AT; Swayze G; Swayze EE; Freier SM
    Nucleic Acid Ther; 2020 Aug; 30(4):215-228. PubMed ID: 32125928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of psoralen-derivatized oligodeoxyribonucleoside methylphosphonates with vesicular stomatitis virus messenger RNA.
    Levis JT; Miller PS
    Antisense Res Dev; 1994; 4(4):223-30. PubMed ID: 7734937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements.
    Reyes-Darias JA; Sánchez-Luque FJ; Berzal-Herranz A
    Virus Res; 2012 Oct; 169(1):63-71. PubMed ID: 22820401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
    Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation.
    Steinhauser IM; Langer K; Strebhardt KM; Spänkuch B
    Biomaterials; 2008 Oct; 29(29):4022-8. PubMed ID: 18653231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.